The chemopreventive properties and therapeutic modulation of green tea polyphenols in oral squamous cell carcinoma.

ISRN Oncol · 2011 · PMC3197077 · PMID 22084729

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In a phase II randomized, placebo-controlled clinical trial of green tea extract (500, 750, or 1,000 mg/m 2 ) in high risk oral premalignant lesions (OPL), the OPL clinical response rate was higher in all green tea extract (GTE) arms versus placebo but did not reach statistical significance [ 82 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.